BIOLINK LIFE SCIENCES, INC.
CARY, NORTH CAROLINA 275137402
Top Industries (NAICS)
| NAICS Code | Obligations | Awards |
|---|---|---|
| 541715 | $207K | 5 |
Contract Awards
3 awards found
BIOLINK - TO INVESTIGATE AND DETERMINE IF TREATMENT WITH RAMATROBAN, ADMINISTERED FOR 28 DAYS TO HOSPITALIZED, NON-ICU PATIENTS WITH COVID-19 PNEUMONIA, REDUCES THE RISK OF SUBSEQUENT DEVELOPMENT OF PASC OVER THE ENSUING 11 MONTHS. PROVIDED DATA
BIOLINK - TO INVESTIGATE AND DETERMINE IF TREATMENT WITH RAMATROBAN, ADMINISTERED FOR 28 DAYS TO HOSPITALIZED, NON-ICU PATIENTS WITH COVID-19 PNEUMONIA, REDUCES THE RISK OF SUBSEQUENT DEVELOPMENT OF PASC OVER THE ENSUING 11 MONTHS. PROVIDED DATA
BIOLINK - TO INVESTIGATE AND DETERMINE IF TREATMENT WITH RAMATROBAN, ADMINISTERED FOR 28 DAYS TO HOSPITALIZED, NON-ICU PATIENTS WITH COVID-19 PNEUMONIA, REDUCES THE RISK OF SUBSEQUENT DEVELOPMENT OF PASC OVER THE ENSUING 11 MONTHS. PROVIDED DATA
Business Details
- UEI
- GUSQRGKRZ4C9
- CAGE Code
- 1WR74
- Address
- 250 QUADE DR
CARY, NC 275137402 - Congressional District
- NC-02
- Phone
- 9193450339
Parent Company
BIOLINK LIFE SCIENCES, INC.
Data Source
This profile is based on federal contract award data from USAspending.gov.
View on USAspending.gov